Afuco™ Anti-Human SLC35F6 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-SLC35F6 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-C2orf18 antibody can be used in the treatment of a C2orf18-associated disease, such as a cancer, particularly pancreatic cancer.
Supplier Creative Biolabs
Product # AFC-553CL
Pricing Inquiry
Host Humanized
Target SLC35F6
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles.
Feedback